Building on our previous studies, we selected four UVs for additional analyses, including tumour immunohistochemistry using markers known to be associated with BRCA1 mutation status [12], and in vitro assays to examine the effects on BRCA1 function. This evidence concerns the gene BRCA1 and neoplasm.